Federal regulators plan to authorize an additional dose for seniors and immunocompromised people in the coming weeks, ahead of the introduction of a newly formulated booster later in the year.
from NYT > Top Stories https://ift.tt/QVp50MI
from NYT > Top Stories https://ift.tt/QVp50MI